NCT07030517 2026-04-14A Study to Assess Safety of Teclistamab in Indian Participants With Relapsed and Refractory Multiple MyelomaJohnson & Johnson Private LimitedPhase 4 Recruiting75 enrolled
NCT05201781 2026-04-13A Long-term Study for Participants Previously Treated With Ciltacabtagene AutoleucelJanssen Research & Development, LLCPhase 4 Recruiting295 enrolled